Table 2 CRS + HIPEC for PC from various primary tumors
From: Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
Author (year) | Primary tumor | Number | Overall survival | |||
|---|---|---|---|---|---|---|
Median (Months) | 1 year (%) | 3 years (%) | 5 years (%) | |||
Jacks (2005) [37] | Small bowel | 6 | 30 | - | - | - |
Gusani (2008) [1] | Unknown | 2 | 26.2 | - | 49 | - |
Breast | 1 | |||||
GIST | 6 | |||||
Gallbladder | 1 | |||||
Liver | 1 | |||||
Adrenal | 1 | |||||
Esophagus | 1 | |||||
Shen (2009) [40] | Unknown | 2 | 22.2 | 66 | 40 | 27 |
Pancreas | 5 | |||||
GIST | 11 | |||||
Sarcoma | 10 | |||||
Gallbladder | 3 | |||||
Adrenal | 1 | |||||
Small bowel | 6 | |||||
Urachus | 5 | |||||
Chua (2009) [3] | Small bowel | 7 | 25 | 57 | 20 | - |
Kerscher (2010) [50] | Small bowel | 3 | - | - | - | |
Glehen (2010) [15] | Unknown | 8 | 34 | 77 | 49 | 37 |
Breast | 2 | |||||
GIST | 3 | |||||
Sarcoma | 28 | |||||
Liver | 2 | |||||
Adrenal | 3 | |||||
Urachus | 4 | |||||
Small bowel | 45 | |||||
Esophagus | 1 | |||||
Kidney | 2 | |||||
Turrini (2012) [52] | Pancreas | 1 | - | - | - | - |
Randle (2013) [48] | Sarcoma | 10 | 21 | - | - | 43 |